Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care

NCT06062979 · clinicaltrials.gov ↗

UNKNOWN

Status

180

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV

Interventions

DRUG: rilpivirine/cabotegravir

Sponsor

Whitman-Walker Institute

Collaborators

[object Object]